Red Blood Cells in Platelet-Rich Plasma: Avoid If at All Possible-Reference-Cited by-同舟云学术

Red Blood Cells in Platelet-Rich Plasma: Avoid If at All Possible

Published:2023-08-30 Issue:9 Volume:11 Page:2425
ISSN:2227-9059
Container-title:Biomedicines
language:en
Short-container-title:Biomedicines

Author:

Gupta Ashim¹²³⁴^ORCID,Maffulli Nicola⁵⁶⁷⁸^ORCID,Jain Vijay Kumar⁹

Affiliation:

1. Regenerative Orthopaedics, Noida 201301, India

2. Future Biologics, Lawrenceville, GA 30043, USA

3. BioIntegrate, Lawrenceville, GA 30043, USA

4. South Texas Orthopaedic Research Institute (STORI Inc.), Laredo, TX 78045, USA

5. Department of Musculoskeletal Disorders, School of Medicine and Surgery, University of Salerno, 84084 Fisciano, Italy

6. San Giovanni di Dio e Ruggi D’Aragona Hospital “Clinica Ortopedica” Department, Hospital of Salerno, 84124 Salerno, Italy

7. Barts and the London School of Medicine and Dentistry, Centre for Sports and Exercise Medicine, Queen Mary University of London, London E1 4DG, UK

8. School of Pharmacy and Bioengineering, Keele University School of Medicine, Stoke on Trent ST5 5BG, UK

9. Department of Orthopaedic Surgery, Atal Bihari Vajpayee Institute of Medical Sciences, Dr. Ram Manohar Lohia Hospital, New Delhi 110001, India

Abstract

The last decade has seen a noticeable upsurge in the use of biologics, including platelet-rich plasma (PRP), for applications in musculoskeletal regenerative medicine [...]

Publisher

MDPI AG

Subject

General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)

Link

https://www.mdpi.com/2227-9059/11/9/2425/pdf

Reference10 articles.

1. Gupta, A., Jeyaraman, M., and Maffulli, N. (2023). Leukocyte-Rich vs. Leukocyte-Poor Platelet-Rich Plasma for the Treatment of Knee Osteoarthritis. Biomedicines, 11.

2. Growth Factor and Catabolic Cytokine Concentrations Are Influenced by the Cellular Composition of Platelet-Rich Plasma;Sundman;Am. J. Sports Med.,2011

3. A call for a standard classification system for future biologic research: The rationale for new PRP nomenclature;Mautner;PM R,2015

4. Everts, P., Onishi, K., Jayaram, P., Lana, J.F., and Mautner, K. (2020). Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int. J. Mol. Sci., 21.

5. Hemolysis and free hemoglobin revisited: Exploring hemoglobin and hem in scavengers as a novel class of therapeutic proteins;Schaer;Blood,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of intra-articular platelet-rich plasma in osteoarthritis knee;Indian Journal of Orthopaedics Surgery;2024-09-15

2. High-Dose Neutrophil-Depleted Platelet-Rich Plasma Therapy for Knee Osteoarthritis: A Retrospective Study;Journal of Clinical Medicine;2024-08-15

3. Growth Factor Concentrate (GFC) for the Management of Osteoarthritis of the Knee: A Systematic Review;Indian Journal of Orthopaedics;2024-05-09

4. Effect of combination of bone marrow aspiration concentrate (BMAC) and platelet-rich plasma (PRP) in anterior cruciate ligament reconstruction;IP International Journal of Orthopaedic Rheumatology;2024-02-15

5. Allogenic Platelet-Rich Plasma for the Treatment of Adhesive Capsulitis;Cureus;2023-10-22